NASDAQ:RGLS
Regulus Therapeutics Inc. Stock News
$2.69
+0.180 (+7.17%)
At Close: May 02, 2024
RGLS Stock Price Increased 56.8%: Why It Happened
08:27pm, Saturday, 13'th Mar 2021
The stock price of Regulus Therapeutics Inc (NASDAQ: RGLS) has increased by 56.8% over the past week. This is why it happened.
RGLS Stock: 7 Things to Know About Red-Hot Regulus Therapeutics
02:58pm, Friday, 12'th Mar 2021
Investors seem to believe something may be cooking with RGLS stock right now, given the outsized move we've seen today on a lack of news. The post RGLS Stock: 7 Things to Know About Red-Hot Regulus Th
Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates
04:07pm, Tuesday, 09'th Mar 2021
LA JOLLA, Calif., March 9, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting mic
Regulus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
04:07pm, Friday, 05'th Mar 2021
LA JOLLA, Calif., March 5, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRN
LA JOLLA, Calif., Feb. 10, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRN
Regulus Announces Addition to Board of Directors
08:07am, Wednesday, 27'th Jan 2021
LA JOLLA, Calif., Jan. 27, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRN
Regulus Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference
08:07am, Tuesday, 05'th Jan 2021
LA JOLLA, Calif., Jan. 5, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNA
Steven Cohen Boots Health Care Exposure With 2 Biotech Stocks
05:27pm, Friday, 11'th Dec 2020
Billionaire investor Steven Cohen (Trades, Portfolio) disclosed earlier this week his firm, Point72 Asset Management, established a 14.37% stake in Regulus Therapeutics Inc. (NASDAQ:RGLS) and a 7.96%
Regulus Therapeutics Announces Closing of $19.4 Million Private Placement of Equity
08:07am, Tuesday, 08'th Dec 2020
LA JOLLA, Calif., Dec. 8, 2020 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNA
Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development
07:00am, Wednesday, 02'nd Dec 2020
MINNEAPOLIS, Dec. 2, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the cli
Regulus Therapeutics Reports Third Quarter 2020 Financial Results and Recent Updates
04:07pm, Thursday, 05'th Nov 2020
LA JOLLA, Calif., Nov. 5, 2020 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNA
Regulus Therapeutics Announces Achievement of Interim Enrollment Milestone Under Collaboration with Sanofi
08:07am, Monday, 02'nd Nov 2020
LA JOLLA, Calif., Nov. 2, 2020 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNA
